Novavax, Inc. (NVAX) Social Stream



Novavax, Inc. (NVAX): $17.32

0.10 (+0.58%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NVAX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 376

in industry

NOVAVAX INC (NVAX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NVAX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 6 $305 $200 $266.2 $16.49 1514.31%
2021-12-16 6 $305 $172 $260.6 $16.49 1480.35%
2021-12-21 6 $305 $209 $268 $16.49 1525.23%
2022-01-03 6 $315 $209 $270 $16.49 1537.36%
2022-01-24 7 $315 $150 $250 $16.49 1416.07%
2022-02-14 7 $315 $150 $232 $16.49 1306.91%
2022-02-22 7 $315 $150 $223.333 $16.49 1254.35%
2022-02-28 7 $294 $150 $215 $16.49 1203.82%
2022-03-02 7 $294 $150 $213 $16.49 1191.69%
2022-03-03 7 $250 $150 $196 $16.49 1088.6%
2022-04-19 7 $250 $150 $194.666 $16.49 1080.51%
2022-05-10 7 $207 $150 $186.833 $16.49 1033.01%
2022-05-11 7 $207 $132 $178.5 $16.49 982.47%
2022-06-03 8 $207 $35 $154.857 $16.49 839.1%
2022-06-08 8 $207 $35 $151.857 $16.49 820.9%
2022-07-22 7 $207 $35 $147.5 $16.49 794.48%
2022-08-09 7 $207 $35 $140.833 $16.49 754.05%
2022-08-13 7 $207 $35 $125.833 $16.49 663.09%
2022-09-17 7 $207 $20 $123.333 $16.49 647.93%
2022-09-22 7 $207 $20 $105.833 $16.49 541.8%
2022-10-13 7 $207 $16 $88.5 $16.49 436.69%
2022-10-19 7 $207 $16 $81.333 $16.49 393.23%
2022-11-09 6 $207 $16 $81.333 $16.49 393.23%
2022-11-10 6 $207 $16 $78.166 $16.49 374.02%

The Trend in the Analyst Price Target


Over the past 26 weeks, NVAX's average price target has gone down $100.33.

NVAX reports an average of 244.89% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-16 6 305 172 260.600 194.92 33.7%
2022-02-14 7 315 150 232.000 80.11 189.6%
2022-02-22 7 315 150 223.333 79.39 181.31%
2022-02-28 7 294 150 215.000 83.37 157.89%
2022-03-03 7 250 150 196.000 80.53 143.39%

NVAX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.5 3 0 1 1 1 6

The Trend in the Broker Recommendations


Over the past 52 weeks, NVAX's average broker recommendation rating worsened by 0.83.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVAX as an investment opportunity.

  • In terms of how NOVAVAX INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2668.08% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NOVAVAX INC's average analyst price target is greater than 2565.98% of them.
  • In terms of how NOVAVAX INC fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is greater than 369.96% of that group.
  • In terms of how NOVAVAX INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -1993.9% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NOVAVAX INC are NBIX, TECH, and RGEN.

What is the outlook for NVAX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.0282 seconds.